Last ¥3,895 JPY
Change Today +195.00 / 5.27%
Volume 2.7M
4507 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
OTC US
OTC US
As of 1:00 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

shionogi & co ltd (4507) Snapshot

Open
¥3,770
Previous Close
¥3,700
Day High
¥3,960
Day Low
¥3,750
52 Week High
03/6/15 - ¥3,960
52 Week Low
04/11/14 - ¥1,733
Market Cap
1.4T
Average Volume 10 Days
1.3M
EPS TTM
¥92.41
Shares Outstanding
351.1M
EX-Date
03/27/15
P/E TM
42.1x
Dividend
¥48.00
Dividend Yield
1.24%
Current Stock Chart for SHIONOGI & CO LTD (4507)

Related News

No related news articles were found.

shionogi & co ltd (4507) Related Businessweek News

No Related Businessweek News Found

shionogi & co ltd (4507) Details

Shionogi & Co., Ltd. manufactures and distributes pharmaceuticals, diagnostic reagents, medical devices, etc. primarily in Asia, North America, and Europe. Its principal products include various prescription drugs, including Osphena to treat postmenopausal vulvar and vaginal atrophy; Crestor tablets for the treatment of hyperlipidemia; Irbetan tablets for the treatment of hypertension; Cymbalta capsules to treat depression, depressive condition, and diabetic neuropathic pain; cancer pain analgesics, such as OxyContin tablets, OxiNorm powders, and OxiFast injections; Tivicay tablets for HIV treatment; Finibax and Finibax solution kit for intravenous drip infusion; Differin gel for the treatment of topical acne vulgaris; Pirespa tablets used to treat idiopathic pulmonary fibrosis; and Rapiacta, an antiviral drug for the treatment of influenza. The company also offers over the counter drugs comprising Popon series of multiple vitamin supplements; and Sedes, a line of analgesic antipyretics. In addition, it provides diagnostics reagents, such as Shionospot Reader and Shionospot BNP, a human brain natriuretic peptide kit; Allerport TARC, a thymus and activation-regulated chemokine kit; Allerport HRT, a reagent for identifying allergens; Brightpoc Flu, an influenza virus diagnostic kit; and Checkart Reader for measuring hemoglobin A1c and glucose levels in blood for use in diagnosing diabetes and other related clinical conditions. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

6,165 Employees
Last Reported Date: 06/25/14
Founded in 1878

shionogi & co ltd (4507) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shionogi & co ltd (4507) Key Developments

Shionogi & Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2015; Announces Consolidated Financial Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Shionogi & Co., Ltd. provided a dividend guidance of ¥24.0 per share for the year ending March 31, 2015, compared to ¥24.0 paid for the same period a year ago. The company announced consolidated financial results for the nine months ended December 31, 2014. For the period, the company reported net sales of ¥200,269 million against ¥218,099 million a year ago. Operating income was ¥36,066 million against ¥48,787 million a year ago. Ordinary income was ¥51,722 million against ¥49,976 million a year ago. Income before income taxes and minority interests was ¥56,226 million against ¥54,283 million a year ago. Net income was ¥26,261 million or ¥78.56 per diluted share against ¥36,160 million or ¥107.98 per diluted share a year ago. For the year ending March 31, 2015, the company now expects net sales of ¥273,500 million, operating income of ¥49,500 million, ordinary income of ¥58,000 million and net income of ¥30,000 million or ¥90.33 per share.

Shionogi & Co., Ltd. to Report Q3, 2015 Results on Feb 02, 2015

Shionogi & Co., Ltd. announced that they will report Q3, 2015 results on Feb 02, 2015

Shionogi & Co., Ltd., Q3 2015 Earnings Call, Feb 02, 2015

Shionogi & Co., Ltd., Q3 2015 Earnings Call, Feb 02, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4507:JP ¥3,895.00 JPY +195.00

4507 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.44 USD +0.43
Pfizer Inc $34.47 USD -0.17
Theravance Inc $19.86 USD +0.22
View Industry Companies
 

Industry Analysis

4507

Industry Average

Valuation 4507 Industry Range
Price/Earnings 40.2x
Price/Sales 4.5x
Price/Book 2.6x
Price/Cash Flow 42.1x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIONOGI & CO LTD, please visit www.shionogi.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.